Drug Action
Lacidipine is a dihydropyridine calcium- channel blocker.
PDF page 194
Loading InternPractice…
Drug reference
Lacidipine is a dihydropyridine calcium- channel blocker.
PDF page 194
Hypertension ▶BY MOUTH ▶Adult: Initially 2 mg daily; increased if necessary to 4 mg daily, then increased if necessary to 6 mg daily, dose increases should occur at intervals of 3–4 weeks, to be taken preferably in the morning
PDF page 194
Acute porphyrias p. 1120. aortic stenosis. avoid within 1 month of myocardial infarction. cardiogenic shock. unstable angina
PDF page 194
Cardiac conduction abnormalities. poor cardiac reserve
PDF page 194
→Appendix 1: calcium channel blockers
PDF page 194
▶Common or very common Abdominal discomfort. asthenia . polyuria ▶Uncommon Ischaemic heart disease ▶Rare or very rare Muscle cramps. tremor
PDF page 194
Manufacturer advises avoid; may inhibit labour.
PDF page 194
Manufacturer advises avoid—no information available.
PDF page 194
Dose adjustments Manufacturer advises consider dose reduction if hypotension occurs.
PDF page 194
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Lacidipine (Non-proprietary) Lacidipine 2 mg Lacidipine 2mg tablets | 28 tablet P £6.85 DT = £2.19 Lacidipine 4 mg Lacidipine 4mg tablets | 28 tablet P £6.85 DT = £2.25 Lacidipine 6 mg Lacidipine 6mg tablets | 28 tablet P £5.75 ▶Molap (Rivopharm (UK) Ltd) Lacidipine 4 mg Molap 4mg tablets | 28 tablet P £2.90 DT = £2.25 ▶Motens (GlaxoSmithKline UK Ltd) Lacidipine 2 mg Motens 2mg tablets | 28 tablet P £2.95 DT = £2.19 Lacidipine 4 mg Motens 4mg tablets | 28 tablet P £3.10 DT = £2.25 eiiii F 168
PDF page 194
Initially 2 mg daily; increased if necessary to
First-line fragment. Read the complete Indications and Dose section above.
PDF page 194